1. Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors
   Hiroshi Kobayashi et al, 2022, Journal of Obstetrics and Gynaecology Research CrossRef
2. Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients
   Inês Soares Marques et al, 2023, International Journal of Molecular Sciences CrossRef
3. Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia
   Hiroshi Kobayashi et al, 2023, Biomedicines CrossRef
4. Plasma microRNA Environment Linked to Tissue Factor Pathway and Cancer-Associated Thrombosis: Prognostic Significance in Ovarian Cancer
   Valéria Tavares et al, 2024, Biomolecules CrossRef
5. Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence
   Yolanda Prado et al, 2023, Advances in Molecular Pathology CrossRef
6. Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning
   Soukaina Amniouel et al, 2024, BioMedInformatics CrossRef
7. Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
   Ryo Tamura et al, 2022, Cancers CrossRef
8. Clear cell carcinoma of the ovary and venous thromboembolism: a systematic review and meta-analysis
   Hamidreza Didar et al, 2023, Current Medical Research and Opinion CrossRef
9. The role of tissue factor pathway inhibitor 2 in the coagulation and fibrinolysis system
   Hiroshi Kobayashi et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef
10. Dual Role of Tissue Factor Pathway Inhibitor 2—A Novel Serodiagnostic Marker for Ovarian Cancer—In Human Cancers
    Hiroshi Kobayashi et al, 2024, International Journal of Translational Medicine CrossRef